Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 23:10.23736/S2724-5683.24.06655-9.
doi: 10.23736/S2724-5683.24.06655-9. Online ahead of print.

Prognostic utility of assessing ventricular-arterial coupling in arterial hypertension and cardiovascular diseases

Affiliations

Prognostic utility of assessing ventricular-arterial coupling in arterial hypertension and cardiovascular diseases

Andrea Vitali et al. Minerva Cardiol Angiol. .

Abstract

The assessment of myocardial function and its coupling with the arterial system, called ventricular-arterial coupling (VAC), is of paramount importance in many clinical fields, from arterial hypertension, which is the main cause of cardiovascular diseases and death, to heart failure. VAC has been the subject of studies for several decades both from an energetic cost and the impact it can exert on cardiovascular performance. Although more attention has been paid to the relationship between the left ventricle and the left arterial circuit in compromised hemodynamic stages, VAC has aroused interest in many other aspects of study, from its application in pathologies of the right sections of the heart to its clinical impact in prevention and cardiovascular risk factors. In this review we will focus on the importance of the hemodynamic data of the VAC in various clinical contexts and its possible applications in the future as a diagnostic and prognostic parameter in the cardiac clinic.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors affirm that they have no conflicts of interest to declare.

References

    1. Figtree GA, Gray MP, Channon KM. Modifiable Risk Factors and Cardiovascular Outcomes. N Engl J Med. 2023. Dec 21;389(25):2401. - PubMed
    1. Holm H, Kruger R, Jujic A, Lamiral Z, Uys AS, Girerd N, Magnusson M. Ventricular-arterial coupling and cardiovascular risk among young adults: The African-PREDICT study. Am J Physiol Heart Circ Physiol. 2023. Aug 1;325(2):H362–H71. Epub 20230630. - PubMed
    1. Gamarra A, Díez-Villanueva P, Salamanca J, Aguilar R, Mahía P, Alfonso F. Development and Clinical Application of Left Ventricular–Arterial Coupling Non-Invasive Assessment Methods. Journal of Cardiovascular Development and Disease [Internet]. 2024; 11(5). - PMC - PubMed
    1. Monge Garcia MI, Santos A. Understanding ventriculo-arterial coupling. Ann Transl Med. 2020. Jun;8(12):795. - PMC - PubMed
    1. Lawson MA, Hansen DE, Gupta DK, Bell SP, Adkisson DW, Mallugari RR, et al. Modification of ventriculo-arterial coupling by spironolactone in nonischemic dilated cardiomyopathy. ESC Heart Fail. 2021. Apr;8(2):1156–66. Epub 20210105. - PMC - PubMed

LinkOut - more resources